omicsonline.com/open-access/2-current-concepts-in-the-presentation-diagnosis-and-management-of-primary-hyperparathyroidism-1584-9341-10-4-2.pdf
Amal Alhefdhi
Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, USA
February 27, 2015
February 2, 2015
Prolactin Receptor in Primary Hyperparathyroidism
PLOS ONE: Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations
Conclusions:
We demonstrate that the prolactin receptor is highly abundant in human parathyroid tissues and that PRLr isoforms expression and PRLr subcellular localisation are altered in parathyroid tumours. Responsiveness of PRLr to physiological levels of prolactin was observed in the form of increased PTH secretion and altered gene transcription with significant increase of RIG-I like receptor, JAK-STAT and Type II interferon signalling pathways. These data suggest a role of the prolactin receptor in parathyroid adenomas.
Conclusions:
We demonstrate that the prolactin receptor is highly abundant in human parathyroid tissues and that PRLr isoforms expression and PRLr subcellular localisation are altered in parathyroid tumours. Responsiveness of PRLr to physiological levels of prolactin was observed in the form of increased PTH secretion and altered gene transcription with significant increase of RIG-I like receptor, JAK-STAT and Type II interferon signalling pathways. These data suggest a role of the prolactin receptor in parathyroid adenomas.
December 12, 2014
Ghrelin receptor alters dopamine signaling
Appetite accomplice: Ghrelin receptor alters dopamine signaling -- ScienceDaily
- Dopamine signaling in the hypothalamus is linked with feeding behavior, and mutations in DRD2 that attenuate dopamine signaling are associated with obesity in humans.
- When mice were treated with a molecule (cabergoline) that selectively activates DRD2, they exhibited anorexia.
November 19, 2014
October 10, 2014
September 23, 2014
Subscribe to:
Posts (Atom)